Regulatory Beat

Jul 01, 2016
BioPharm International
Agency guidance and industry standards aim to reduce lapses and improve quality operations.
Jun 01, 2016
BioPharm International
More efforts are needed to raise awareness of biosimilars among physicians and patients in Europe and address scepticisms about the quality and safety of biosimilars.
Jun 01, 2016
BioPharm International
FDA and bio/pharma companies get serious about continuous manufacturing to ensure product quality.
Apr 01, 2016
BioPharm International
The campaign against opioid abuse opens door to more innovative therapies.
Apr 01, 2016
BioPharm International
Global outbreaks energize vaccine R&D and drive production modernization.
Mar 09, 2016
The five-year Medicare initiative seeks to change the way in which drugs are reimbursed under Medicare Part B.
Mar 01, 2016
BioPharm International
Policy makers debate strategies for promoting access to less costly medicines.
Feb 01, 2016
BioPharm International
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.
Dec 01, 2015
BioPharm International
FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
Nov 01, 2015
BioPharm International
New program emphasizes quality, risk, and global collaboration.
native1_300x100
lorem ipsum